Home Featured Page 301

Featured

Latest

Burning Heroes Pitch Competition

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and What Comes Next; Pre-EO, DEA Poured Cold Water on Right to Try

God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive Order, and What Comes Next

Spotlight on Psychedelic Pioneers: Albert Hofmann

Joe Rogan: Dedemonizing Psychedelics

PsyBio Completes Reverse Take-Over Transaction

Psychedelic Business News Spotlight: February 19, 2021

Psychedelic Bulletin: California Bill Aims to Decriminalize Psychedelics; MindMed Acquires HealthMode;...

Differentiating DMT and Near-Death Experiences

New Texas Legislation Will Allow State to Study MDMA, Psilocybin as...

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke...

PTSF47 – Covid, Ketamine, and Human Rights

Massachusetts General Hospital to Study How Psychedelics Influence the Brain

EDITOR PICKS

Burning Heroes Pitch Competition

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and What Comes Next; Pre-EO, DEA Poured Cold Water on Right to Try

God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive Order, and What Comes Next

Spotlight on Psychedelic Pioneers: Albert Hofmann

Joe Rogan: Dedemonizing Psychedelics

PsyBio Completes Reverse Take-Over Transaction

Psychedelic Business News Spotlight: February 19, 2021

Psychedelic Bulletin: California Bill Aims to Decriminalize Psychedelics; MindMed Acquires HealthMode;...

Differentiating DMT and Near-Death Experiences

New Texas Legislation Will Allow State to Study MDMA, Psilocybin as...

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke...

PTSF47 – Covid, Ketamine, and Human Rights

Massachusetts General Hospital to Study How Psychedelics Influence the Brain

EDITOR PICKS

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY